Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M26,940Revenue $M8,054Net Margin (%)14.0Z-Score5.0
Enterprise Value $M28,146EPS $6.5Operating Margin %19.0F-Score4
P/E(ttm))23.4Cash Flow Per Share $8.2Pre-tax Margin (%)18.0Higher ROA y-yN
Price/Book5.310-y EBITDA Growth Rate %7.5Quick Ratio2.1Cash flow > EarningsY
Price/Sales3.35-y EBITDA Growth Rate %4.8Current Ratio2.7Lower Leverage y-yY
Price/Cash Flow9.5y-y EBITDA Growth Rate %20.5ROA % (ttm)9.7Higher Current Ratio y-yN
Dividend Yield %1.6Insider Buy (3m)0ROE % (ttm)22.9Less Shares Outstanding y-yN
Payout Ratio %36.0Shares Outstanding M192ROI % (ttm)16.2Gross Margin Increase y-yN

Gurus Latest Trades with BDX

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BDXJean-Marie Eveillard 2014-09-30 Add0.07%$112.63 - $120.21
($116.86)
$ 140.3320%Add 42.41%829,770
BDXJoel Greenblatt 2014-09-30 Add0.03%$112.63 - $120.21
($116.86)
$ 140.3320%Add 26.52%101,597
BDXRay Dalio 2014-09-30 Buy 0.02%$112.63 - $120.21
($116.86)
$ 140.3320%New holding, 25358 sh.25,358
BDXRuane Cunniff 2014-09-30 Sold Out $112.63 - $120.21
($116.86)
$ 140.3320%Sold Out0
BDXJohn Hussman 2014-09-30 Reduce-1.14%$112.63 - $120.21
($116.86)
$ 140.3320%Reduce -71.43%50,000
BDXJohn Hussman 2014-06-30 Add0.69%$111.18 - $120.33
($116.18)
$ 140.3321%Add 75%175,000
BDXJean-Marie Eveillard 2014-06-30 Buy 0.17%$111.18 - $120.33
($116.18)
$ 140.3321%New holding, 582656 sh.582,656
BDXJoel Greenblatt 2014-06-30 Buy 0.12%$111.18 - $120.33
($116.18)
$ 140.3321%New holding, 80303 sh.80,303
BDXChris Davis 2014-06-30 Sold Out $111.18 - $120.33
($116.18)
$ 140.3321%Sold Out0
BDXRay Dalio 2014-06-30 Sold Out $111.18 - $120.33
($116.18)
$ 140.3321%Sold Out0
BDXMichael Price 2014-06-30 Reduce-0.57%$111.18 - $120.33
($116.18)
$ 140.3321%Reduce -22.86%135,000
BDXRay Dalio 2014-03-31 Reduce$105.4 - $116.81
($112.54)
$ 140.3325%Reduce -30.27%2,995
BDXMichael Price 2014-03-31 Reduce-0.36%$105.4 - $116.81
($112.54)
$ 140.3325%Reduce -12.5%175,000
BDXYacktman Focused Fund 2014-03-31 Reduce-0.26%$105.4 - $116.81
($112.45)
$ 140.3325%Reduce -32.84%450,000
BDXDonald Yacktman 2014-03-31 Reduce-0.2%$105.4 - $116.81
($112.45)
$ 140.3325%Reduce -25.8%1,300,476
BDXJohn Hussman 2014-03-31 Reduce-0.2%$105.4 - $116.81
($112.45)
$ 140.3325%Reduce -20%100,000
BDXYacktman Fund 2014-03-31 Reduce-0.12%$105.4 - $116.81
($112.45)
$ 140.3325%Reduce -15.38%660,000
BDXRobert Olstein 2014-03-31 Reduce-0.12%$105.4 - $116.81
($112.54)
$ 140.3325%Reduce -12.31%57,000
BDXArnold Van Den Berg 2014-03-31 Sold Out -0.02%$105.4 - $116.81
($112.45)
$ 140.3325%Sold Out0
BDXJohn Hussman 2013-12-31 Add0.2%$98.33 - $110.6
($106.28)
$ 140.3332%Add 25%125,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BDX is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
BDX Ray Dalio 2014-09-3025,3580.010.02New Buy
BDX Jean-Marie Eveillard 2014-09-30829,7700.430.23+42.41%
BDX Joel Greenblatt 2014-09-30101,5970.050.12+26.52%
BDX Richard Pzena 2014-09-302,731,4081.421.7+5.04%
BDX Yacktman Focused Fund 2014-09-30450,0000.230.55
BDX Vanguard Health Care Fund 2014-09-302,393,1001.250.7
BDX Yacktman Fund 2014-09-30660,0000.340.65
BDX Robert Olstein 2014-09-3054,0000.030.8
BDX Michael Price 2014-09-30135,0000.071.9
BDX Donald Yacktman 2014-09-301,303,5960.680.62-0.05%
BDX Dodge & Cox 2014-09-3016,5100.010-1.61%
BDX Mario Gabelli 2014-09-30501,2720.260.31-8%
BDX John Hussman 2014-09-3050,0000.030.49-71.43%
BDX Ruane Cunniff 2014-09-30000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


BDX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Tharby Linda MSegment Pres. Life Sciences 2014-10-01Sell0$0view
Polen Thomas E JrSegment President, Medical 2014-10-01Sell0$0view
Sichak StephenSenior Vice President 2014-06-12Sell1,456$118.2519.46view
COHEN GARY MExecutive Vice President 2014-06-10Sell12,476$119.2418.47view
SHERMAN JEFFREY SSr. VP and General Counsel 2014-06-09Sell7,877$120.2417.48view
KOZY WILLIAM AExecutive Vice President 2014-06-05Sell7,092$117.9819.73view
SHERMAN JEFFREY SSr. VP and General Counsel 2014-03-06Sell1,303$115.1622.66view
Mercurio JosephVP and Corporate Controller 2014-01-28Sell0$022.66view
Sichak StephenSenior Vice President 2013-12-16Sell344$105.8233.49view
KOZY WILLIAM AExecutive Vice President 2013-11-12Sell9,597$108.330.43view

Press Releases about BDX :

    Quarterly/Annual Reports about BDX:

    News about BDX:

    Articles On GuruFocus.com
    Becton, Dickinson and Co. (BDX) Dividend Stock Analysis Nov 19 2014 
    Dividend Aristocrats in Focus Part 18 of 54: Becton, Dickinson & Company Oct 14 2014 
    Weekly 52-Week Highs Highlight: BDX, DUK, CFN, INFY Oct 12 2014 
    Becton and Dickinson Provides Shareholders with Solid Returns Oct 03 2014 
    Medtronic Inc. (MDT) Dividend Stock Analysis Sep 12 2014 
    Critical Investor John Hussman's Top Five Q2 Holdings Aug 01 2014 
    Top Three Holdings with Promising Outlook Jul 15 2014 
    Becton, Dickinson and Co. (BDX) Dividend Stock Analysis May 30 2014 
    CR Bard Focuses on Small to Medium-Sized Deals Apr 04 2014 
    Weekly 52-Week Highs Highlight: SRCL, BDX, LINTB, NI Jan 20 2014 


    More From Other Websites
    BECTON DICKINSON & CO Files SEC form 10-K, Annual Report Nov 26 2014
    BD to Present at the 26th Annual Piper Jaffray Healthcare Conference Nov 25 2014
    BD to Present at the 26th Annual Piper Jaffray Healthcare Conference Nov 25 2014
    Becton Dickinson: CareFusion Buy Adding More To EPS Nov 25 2014
    BECTON DICKINSON & CO Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial... Nov 25 2014
    BD Board Declares Dividend Nov 25 2014
    BD Board Declares Dividend Nov 25 2014
    Care Fusion & Becton, Dickinson Hit Highs on Merger Progress Nov 24 2014
    Becton Dickinson And CareFusion Announce Expiration Of HSR Act Waiting Period In Proposed... Nov 20 2014
    Becton Dickinson And CareFusion Announce Expiration Of HSR Act Waiting Period In Proposed... Nov 20 2014
    Britain begins review to speed access to new drugs Nov 20 2014
    Britain begins review to speed access to new drugs Nov 20 2014
    Cramer: Stocks That Stand Out Nov 17 2014
    BECTON DICKINSON & CO Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a... Nov 14 2014
    Becton, Dickinson Ordered to Clarify False Syringe Claims Nov 13 2014
    BD to Present at the Stifel 2014 Healthcare Conference Nov 11 2014
    BD to Present at the Stifel 2014 Healthcare Conference Nov 11 2014
    U.S. judge orders Becton Dickinson to correct false syringe claims Nov 11 2014
    Theranos, Tigers, Eiffel Tower: Intellectual Property Nov 05 2014
    Becton Dickinson (BDX) Earnings Report: Q4 2014 Conference Call Transcript Nov 04 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK